Pfizer said on Thursday it completed an acquisition worth up to $10 billion of biotech firm Metsera after winning shareholder ...

Jay Lalezari, CEO of CytoDyn, explains how the CCR5 receptor has emerged as a pivotal target in metastatic cancers due to its ...

A medication long known for its use in substance abuse treatment is getting a second life in the world of functional medicine ...

A new study published in Biomedicine & Pharmacotherapy reports that a blend of cannabidiol (CBD) and cannabidivarin (CBDV) ...

NIMS has been developing chemical sensors as a key component of artificial olfaction technology (olfactory sensors), with the ...

The surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric ...

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn ...

Retatrutide is a powerful experimental weight loss drug that currently lacks FDA approval. Learn how it works, plus the legal and safety risks of buying retatrutide online.

GLP-1 medications silence "food noise" for many, but have high discontinuation rates and significant side effects. Is there a ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

In a discovery that could shift labor and delivery practices around the world, researchers at Michigan State University have ...

Your eyes—retinal blood vessels and retinal imaging—may help predict heart disease, according to a new study. Here, doctors ...